Moors & Cabot’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-17,833
Closed -$1.77M 650
2019
Q3
$1.77M Buy
17,833
+273
+2% +$27.1K 0.2% 127
2019
Q2
$1.62M Buy
17,560
+2,010
+13% +$186K 0.21% 122
2019
Q1
$1.46M Buy
15,550
+8,049
+107% +$758K 0.2% 124
2018
Q4
$481K Sell
7,501
-1,615
-18% -$104K 0.08% 259
2018
Q3
$813K Buy
9,116
+59
+0.7% +$5.26K 0.1% 223
2018
Q2
$725K Buy
9,057
+1,665
+23% +$133K 0.1% 232
2018
Q1
$659K Buy
7,392
+1,914
+35% +$171K 0.09% 265
2017
Q4
$569K Buy
5,478
+1,285
+31% +$133K 0.08% 291
2017
Q3
$611K Buy
4,193
+105
+3% +$15.3K 0.09% 271
2017
Q2
$529K Buy
4,088
+487
+14% +$63K 0.09% 275
2017
Q1
$447K Sell
3,601
-207
-5% -$25.7K 0.08% 295
2016
Q4
$442K Buy
3,808
+501
+15% +$58.2K 0.07% 311
2016
Q3
$344K Sell
3,307
-475
-13% -$49.4K 0.06% 343
2016
Q2
$377K Sell
3,782
-2,595
-41% -$259K 0.07% 315
2016
Q1
$638K Buy
6,377
+525
+9% +$52.5K 0.12% 217
2015
Q4
$702K Sell
5,852
-1,330
-19% -$160K 0.13% 203
2015
Q3
$780K Sell
7,182
-472
-6% -$51.3K 0.14% 179
2015
Q2
$891K Buy
7,654
+584
+8% +$68K 0.14% 172
2015
Q1
$822K Sell
7,070
-130
-2% -$15.1K 0.14% 179
2014
Q4
$804K Buy
7,200
+860
+14% +$96K 0.14% 176
2014
Q3
$598K Buy
6,340
+1,350
+27% +$127K 0.1% 222
2014
Q2
$428K Buy
+4,990
New +$428K 0.07% 300